Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
'One stop' haematuria clinic in Fremantle Hospital, Western Australia: a report of the first 500 patients.
Ooi WL, Lee F, Wallace DM, Hayne D.
BJU Int. 2011 Nov;108 Suppl 2:62-6. doi: 10.1111/j.1464-410X.2011.10711.x.
Related citations
Male flexible cystoscopy: does waiting after insertion of topical anaesthetic lubricant improve patient comfort?
Losco G, Antoniou S, Mark S.
BJU Int. 2011 Nov;108 Suppl 2:42-4. doi: 10.1111/j.1464-410X.2011.10696.x.
Oncological outcomes of robot-assisted radical cystectomy.
Choudhury SM, Mahesan NM, Elhage O, Khan MS, Dasgupta P.
BJU Int. 2011 Dec;108(11):1679-80. doi: 10.1111/j.1464-410X.2011.10646.x. Epub 2011 Nov 1. No abstract available.
From Leonardo to da Vinci: the history of robot-assisted surgery in urology.
Yates DR, Vaessen C, Roupret M.
BJU Int. 2011 Dec;108(11):1708-13; discussion 1714. doi: 10.1111/j.1464-410X.2011.10576.x. Epub 2011 Sep 27.
The sensitivity of fluorescent-light cystoscopy for the detection of carcinoma in situ (CIS) of the bladder: a meta-analysis with comments on gold standard.
Isfoss BL.
BJU Int. 2011 Dec;108(11):1703-7. doi: 10.1111/j.1464-410X.2011.10485.x. Epub 2011 Jul 20. Review.
Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.
Gakis G, Todenhöfer T, Renninger M, Schilling D, Sievert KD, Schwentner C, Stenzl A.
BJU Int. 2011 Dec;108(11):1800-5. doi: 10.1111/j.1464-410X.2011.10234.x. Epub 2011 Apr 20.
The economics of robotic cystectomy: cost comparison of open versus robotic cystectomy.
Lee R, Ng CK, Shariat SF, Borkina A, Guimento R, Brumit KF, Scherr DS.
BJU Int. 2011 Dec;108(11):1886-92. doi: 10.1111/j.1464-410X.2011.10114.x. Epub 2011 Apr 18.
A one-port pneumovesicum method in en bloc laparoscopic nephroureterectomy with bladder cuff resection is feasible and safe for upper tract transitional cell carcinoma.
Zou X, Zhang G, Wang X, Yuan Y, Xiao R, Wu G, Long D, Xu H, Wu Y, Liu F.
BJU Int. 2011 Nov;108(9):1497-500. doi: 10.1111/j.1464-410X.2010.10057.x. Epub 2011 Apr 11.
R11, a novel cell-permeable peptide, as an intravesical delivery vehicle.
Hsieh JT, Zhou J, Gore C, Zimmern P.
BJU Int. 2011 Nov;108(10):1666-71. doi: 10.1111/j.1464-410X.2011.10185.x. Epub 2011 Mar 31.
The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands.
Miyazaki J, Kawai K, Kojima T, Oikawa T, Joraku A, Shimazui T, Nakaya A, Yano I, Nakamura T, Harashima H, Akaza H.
BJU Int. 2011 Nov;108(9):1520-6. doi: 10.1111/j.1464-410X.2010.10056.x. Epub 2011 Feb 11.
Characterizing genetic interactions in human disease association studies using statistical epistasis networks.
Hu T, Sinnott-Armstrong NA, Kiralis JW, Andrew AS, Karagas MR, Moore JH.
BMC Bioinformatics. 2011 Sep 12;12:364.
Association of secondhand smoke exposures with DNA methylation in bladder carcinomas.
Wilhelm-Benartzi CS, Christensen BC, Koestler DC, Andres Houseman E, Schned AR, Karagas MR, Kelsey KT, Marsit CJ.
Cancer Causes Control. 2011 Aug;22(8):1205-13. Epub 2011 Jun 10.
Re: Ben J. Challacombe, Bernard H. Bochner, Prokar Dasgupta, et al. The role of laparoscopic and robotic cystectomy in the management of muscle-invasive bladder cancer with special emphasis on cancer control and complications. Eur Urol 2011;60:767-75.
Simonato A, Ennas M.
Eur Urol. 2012 Apr;61(4):e29; author reply e30. Epub 2011 Dec 21. No abstract available.
Re: Sven van den Bosch, J. Alfred Witjes. Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review. Eur Urol 2011;60:493-500.
Banerjee S, Kumar V.
Eur Urol. 2012 Mar;61(3):e13. Epub 2011 Dec 22. No abstract available.
Error occurred: cannot get document summary
Reply from Authors re: J. Alfred Witjes. Prognosis of T1G3 Bladder Cancer: How Well Can We Predict Progression? Eur Urol 2012;62:126-7.
Palou J, Rodríguez Faba O, Peña JA.
Eur Urol. 2012 Jul;62(1):128-9. Epub 2011 Dec 7. No abstract available.
Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy.
Maurer T, Souvatzoglou M, Kübler H, Opercan K, Schmidt S, Herrmann K, Stollfuss J, Weirich G, Haller B, Gschwend JE, Schwaiger M, Krause BJ, Treiber U.
Eur Urol. 2012 May;61(5):1031-8. Epub 2011 Dec 14.
Carboplatin-gemcitabine combination chemotherapy upregulates AKR1B10 expression in bladder cancer.
Hashimoto Y, Imanishi K, Tokui N, Okamoto T, Okamoto A, Hatakeyama S, Yoneyama T, Koie T, Kamimura N, Ohyama C.
Int J Clin Oncol. 2011 Dec 27. [Epub ahead of print]
Chlorin-based photodynamic therapy enhances the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in bladder cancer cells.
Szliszka E, Czuba ZP, Kawczyk-Krupka A, Sieron-Stoltny K, Sieron A, Krol W.
Med Sci Monit. 2012 Jan;18(1):BR47-53.
Bladder cancer: Improving the management of T1 bladder cancer.
Payton S.
Nat Rev Urol. 2011 Dec 27;9(1):8. doi: 10.1038/nrurol.2011.210. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on